Franklin Resources’s Anavex Life Sciences AVXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-71,908
Closed -$221K 3205
2026
Q1
$221K Sell
71,908
-652
-0.9% -$2.82K ﹤0.01% 2763
2025
Q4
$258K Sell
72,560
-302,664
-81% -$1.85M ﹤0.01% 2686
2025
Q3
$11M Buy
375,224
+302,444
+416% +$3.07M ﹤0.01% 1135
2025
Q2
$671K Buy
72,780
+6,662
+10% +$56.9K ﹤0.01% 2189
2025
Q1
$567K Buy
66,118
+7,561
+13% +$71.4K ﹤0.01% 2214
2024
Q4
$629K Hold
58,557
﹤0.01% 2187
2024
Q3
$317K Buy
58,557
+3,674
+7% +$21.2K ﹤0.01% 2469
2024
Q2
$232K Buy
54,883
+36,711
+202% +$148K ﹤0.01% 2524
2024
Q1
$92.5K Sell
18,172
-7,337
-29% -$41.3K ﹤0.01% 2721
2023
Q4
$237K Buy
25,509
+11,579
+83% +$79.7K ﹤0.01% 2284
2023
Q3
$91.2K Sell
13,930
-20,771
-60% -$165K ﹤0.01% 2467
2023
Q2
$282K Buy
+34,701
New +$297K ﹤0.01% 2238

Other funds holding AVXL

Franklin Resources's AVXL Position: Q2 2026 in Review

Franklin Resources sold out of Anavex Life Sciences (AVXL) in Q2 2026, closing a stake of 71,908 shares — an estimated $221K sold.

Franklin Resources first reported a position in AVXL in Q2 2023 and held it in 12 quarters. The position peaked at $11M in Q3 2025. 179 funds tracked by Wall St. Rank hold AVXL as of Q2 2026.

  • Franklin Resources reported no remaining Anavex Life Sciences position as of Q2 2026 after selling out during the quarter.
  • Franklin Resources sold 71,908 Anavex Life Sciences shares in Q2 2026, an estimated $221K.
  • Franklin Resources first reported a position in Anavex Life Sciences in Q2 2023 and held it in 12 quarters.
  • Franklin Resources's Anavex Life Sciences position peaked at $11M in Q3 2025.
  • 179 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.